Business
Bank of America's GLP-1 Drug Spending
Bank of America is spending $250 million a year on GLP-1 drugs for its employees, according to the CEO. The rising cost of these medications has become a significant challenge for employers.
Coverage timeline — 1 article
CNBC
Employers have grappled with soaring demand for GLP-1 drugs such as Ozempic and Wegovy, which can cost thousands of dollars per patient annually.
2026-08-05 14:49 UTC